Blueprint Medicines Corp
NASDAQ:BPMC

Watchlist Manager
Blueprint Medicines Corp Logo
Blueprint Medicines Corp
NASDAQ:BPMC
Watchlist
Price: 101.51 USD -1.45% Market Closed
Market Cap: 6.6B USD

Intrinsic Value

The intrinsic value of one BPMC stock under the Base Case scenario is 114.1 USD. Compared to the current market price of 101.51 USD, Blueprint Medicines Corp is Undervalued by 11%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BPMC Intrinsic Value
114.1 USD
Undervaluation 11%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Blueprint Medicines Corp

Valuation History Unavailable

Historical valuation for BPMC cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Blueprint Medicines Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Blueprint Medicines Corp

Current Assets 702.1m
Cash & Short-Term Investments 576.2m
Receivables 79.8m
Other Current Assets 46m
Non-Current Assets 493.5m
Long-Term Investments 323.5m
PP&E 97.7m
Other Non-Current Assets 72.3m
Efficiency

Free Cash Flow Analysis
Blueprint Medicines Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Blueprint Medicines Corp

Revenue
562.1m USD
Cost of Revenue
-19.8m USD
Gross Profit
542.3m USD
Operating Expenses
-716.7m USD
Operating Income
-174.3m USD
Other Expenses
18.6m USD
Net Income
-155.7m USD
Fundamental Scores

BPMC Profitability Score
Profitability Due Diligence

Blueprint Medicines Corp's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
34/100
Profitability
Score

Blueprint Medicines Corp's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

BPMC Solvency Score
Solvency Due Diligence

Blueprint Medicines Corp's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Average D/E
40/100
Solvency
Score

Blueprint Medicines Corp's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BPMC Price Targets Summary
Blueprint Medicines Corp

Wall Street analysts forecast BPMC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BPMC is 128.01 USD with a low forecast of 83.83 USD and a high forecast of 175.35 USD.

Lowest
Price Target
83.83 USD
17% Downside
Average
Price Target
128.01 USD
26% Upside
Highest
Price Target
175.35 USD
73% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Blueprint Medicines Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for BPMC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BPMC Insider Trading
Buy and sell transactions by insiders

BPMC News

Other Videos
What is the Intrinsic Value of one BPMC stock?

The intrinsic value of one BPMC stock under the Base Case scenario is 114.1 USD.

Is BPMC stock undervalued or overvalued?

Compared to the current market price of 101.51 USD, Blueprint Medicines Corp is Undervalued by 11%.

Back to Top